Cargando…

The changing demography of the cystic fibrosis population: forecasting future numbers of adults in the UK

Improvements in management of cystic fibrosis (CF) through specialist centres in the UK have been associated with a step-change in life expectancy. With increasing numbers of adult patients there is a need to review health care provision to ensure it is sufficient to meet future needs. We used UK CF...

Descripción completa

Detalles Bibliográficos
Autores principales:	Keogh, Ruth H., Tanner, Kamaryn, Simmonds, Nicholas J., Bilton, Diana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7327064/ https://www.ncbi.nlm.nih.gov/pubmed/32606329 http://dx.doi.org/10.1038/s41598-020-67353-3

Ejemplares similares

Mediation of the total effect of cystic fibrosis‐related diabetes on mortality: A UK Cystic Fibrosis Registry cohort study
por: Tanner, Kamaryn T., et al.
Publicado: (2022)

Data Resource Profile: The UK Cystic Fibrosis Registry
por: Taylor-Robinson, David, et al.
Publicado: (2018)

Up-to-date and projected estimates of survival for people with cystic fibrosis using baseline characteristics: A longitudinal study using UK patient registry data()
por: Keogh, Ruth H., et al.
Publicado: (2018)

The emerging burden of liver disease in cystic fibrosis patients: A UK nationwide study
por: Toledano, M. B., et al.
Publicado: (2019)

The fungal airway microbiome in cystic fibrosis and non-cystic fibrosis bronchiectasis
por: Cuthbertson, Leah, et al.
Publicado: (2021)

Statistical demography and forecasting
por: Alho, Juha M, et al.
Publicado: (2005)

Results from an online survey of adults with cystic fibrosis: Accessing and using life expectancy information
por: Keogh, Ruth H., et al.
Publicado: (2019)

Relationship between pulmonary exacerbations and daily physical activity in adults with cystic fibrosis
por: Savi, Daniela, et al.
Publicado: (2015)

Randomised cross-over trial evaluating the short-term effects of non-invasive ventilation as an adjunct to airway clearance techniques in adults with cystic fibrosis
por: Stanford, Gemma, et al.
Publicado: (2019)

Using Negative Control Outcomes and Difference-in-Differences Analysis to Estimate Treatment Effects in an Entirely Treated Cohort: The Effect of Ivacaftor in Cystic Fibrosis
por: Newsome, Simon J, et al.
Publicado: (2021)

Methods of analysis for survival outcomes with time-updated mediators, with application to longitudinal disease registry data
por: Tanner, Kamaryn T, et al.
Publicado: (2022)

Clinimetric analysis of outcome measures for airway clearance in people with cystic fibrosis: a systematic review
por: Stanford, Gemma E., et al.
Publicado: (2022)

Burkholderia cepacia complex and limited cutaneous vasculitis in patients with cystic fibrosis: a case series
por: Kayria, Muttardi, et al.
Publicado: (2017)

Pulmonary Exacerbations in Adults With Cystic Fibrosis: A Grown-up Issue in a Changing Cystic Fibrosis Landscape
por: Stanford, Gemma E., et al.
Publicado: (2021)

Investigating outcome measures for assessing airway clearance techniques in adults with cystic fibrosis: protocol of a single-centre randomised controlled crossover trial
por: Stanford, Gemma, et al.
Publicado: (2020)

Hyperglycemia and Death in Cystic Fibrosis–Related Diabetes
por: Adler, Amanda I., et al.
Publicado: (2011)

Cystic fibrosis modulator therapy can reverse cystic bronchiectasis
por: Middleton, Peter G., et al.
Publicado: (2023)

Treatment patterns in people with cystic fibrosis: have they changed since the introduction of ivacaftor?
por: Granger, Emily, et al.
Publicado: (2022)

Diabetes as a Determinant of Mortality in Cystic Fibrosis
por: Chamnan, Parinya, et al.
Publicado: (2010)

Dynamic Prediction of Survival in Cystic Fibrosis: A Landmarking Analysis Using UK Patient Registry Data
por: Keogh, Ruth H., et al.
Publicado: (2019)

Improved survival at low lung function in cystic fibrosis: cohort study from 1990 to 2007
por: George, P M, et al.
Publicado: (2011)

Data from the US and UK cystic fibrosis registries support disease modification by CFTR modulation with ivacaftor
por: Bessonova, Leona, et al.
Publicado: (2018)

Pathways to global-change effects on biodiversity: new opportunities for dynamically forecasting demography and species interactions
por: Paniw, Maria, et al.
Publicado: (2023)

Optimising inhaled mannitol for cystic fibrosis in an adult population
por: Flume, Patrick A., et al.
Publicado: (2015)

Real-World Outcomes Among Patients with Cystic Fibrosis Treated with Ivacaftor: 2012–2016 Experience
por: Higgins, Mark, et al.
Publicado: (2020)

Health State Utility Data in Cystic Fibrosis: A Systematic Review
por: Mohindru, Bishal, et al.
Publicado: (2019)

Future Comorbidities in an Aging Cystic Fibrosis Population
por: Ticona, Javier Humberto, et al.
Publicado: (2023)

Future therapies for cystic fibrosis
por: Allen, Lucy, et al.
Publicado: (2023)

Cystic Fibrosis Gene Therapy in the UK and Elsewhere
por: Griesenbach, Uta, et al.
Publicado: (2015)

A guide to interpreting estimated median age of survival in cystic fibrosis patient registry reports
por: Keogh, Ruth H., et al.
Publicado: (2018)

US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis
por: Floto, R Andres, et al.
Publicado: (2016)

Lung function in children with cystic fibrosis in the USA and UK: a comparative longitudinal analysis of national registry data
por: Schlüter, Daniela K, et al.
Publicado: (2022)

Assessing the health risk of living near composting facilities on lung health, fungal and bacterial disease in cystic fibrosis: a UK CF Registry study
por: Khan, Muhammad Saleem, et al.
Publicado: (2022)

Prevalence of Nontuberculous Mycobacteria in Cystic Fibrosis Clinics, United Kingdom, 2009
por: Seddon, Paul, et al.
Publicado: (2013)

US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis: executive summary
por: Floto, R Andres, et al.
Publicado: (2016)

Genetic Determinants and Epidemiology of Cystic Fibrosis–Related Diabetes: Results from a British cohort of children and adults
por: Adler, Amanda I., et al.
Publicado: (2008)

Demography and disorders of the French Bulldog population under primary veterinary care in the UK in 2013
por: O’Neill, Dan G., et al.
Publicado: (2018)

Changing demography and the challenge of dementia in India
por: Ravindranath, Vijayalakshmi, et al.
Publicado: (2021)

Epidemiology of Nontuberculous Mycobacteria Infection in Children and Young People With Cystic Fibrosis: Analysis of UK Cystic Fibrosis Registry
por: Gardner, Aaron I, et al.
Publicado: (2019)

Injecting drug users in Scotland, 2006: Listing, number, demography, and opiate-related death-rates
por: King, Ruth, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_fd2e6943vtcvv7d1e0smj5i5ta